BMEA vs BSX · $94.7M cap vs P/E 20, rev $16.75B
Biomea Fusion Inc (BMEA) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
BMEA does not have a complete income-statement cache yet.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BMEA currently screens at market cap $94.7M. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BMEA and BSX stock pages for the full models.
Not investment advice.